TITLE

triple-marker test

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p2240
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of "triple-marker test" is presented. It refers to the testing for Down syndrome in which the maternal serum levels of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol are assessed. The test is also used as an alternative to amniocentesis.
ACCESSION #
21249470

 

Related Articles

  • A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies. Banerjee, Subhasis; Smallwood, Alan; Chambers, Anne E.; Papageorghiou, Aris; Loosfelt, Hugues; Spencer, Kevin; Campbell, Stuart; Nicolaides, Kypros // Reproductive Biology & Endocrinology;2005, Vol. 3, p25 

    Human chorionic gonadotrophin (hCG) is released from placental trophoblasts and is involved in establishing pregnancy by maintaining progesterone secretion from the corpus luteum. Serum hCG is detected in the maternal circulation within the first 2-3 wks of gestation and peaks at the end of the...

  • DOWN SYNDROME CAN BE DETECTED IN FIRST TRIMESTER OF PREGNANCY. White, Kristin // Journal of Women's Health;Jun98, Vol. 7 Issue 5, p497 

    The article discusses the diagnosis of Down's Syndrome during pregnancy. It suggests that, by using two blood tests instead of the standard one may detect Down syndrome as early as the first trimester of pregnancy. Blood levels of pregnancy associated protein A and human chorionic gonadotropin...

  • Second trimester screening for Down's syndrome: 7 years experience. Beaman, J. M.; Goldie, D. J. // Journal of Medical Screening;Sep2001, Vol. 8 Issue 3, p128 

    OBJECTIVES:To evaluate the effectiveness of the first 7 years of a programme for second trimester antenatal screening for Down's syndrome, using α-fetoprotein (αFP) and total human chorionic gonadotropin (hCG) as maternal serum markers. METHODS:A clinical biochemistry laboratory providing...

  • Data analysis on prenatal screening of Down's syndrome among 5823 cases in pregnant metaphase. Xiaoqing Lu; Ruyu Tian; Lihua Liu // Journal of Chemical & Pharmaceutical Research;2013, Vol. 5 Issue 12, p1074 

    To use the results of second trimester Down's syndrome screening, analysis the relevance of serum AFP, uE3 and a median multiple of β-HCG with gestational age and weight , in order to improve the rate of detection and accuracy for Down syndrome screening. According to the median of 5823 cases...

  • Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome. Viuff, Mette Hansen; Stochholm, Kirstine; Uldbjerg, Niels; Nielsen, Birgitte Bruun; Gravholt, Claus Højbjerg; Danish Fetal Medicine Study Group // Human Reproduction;Oct2015, Vol. 30 Issue 10, p2419 

    Study Question: How does a national prenatal screening program for Down syndrome (DS) perform in detecting sex chromosome abnormalities (SCAs)-Turner syndrome (TS), Klinefelter syndrome, 47,XXX and 47,XYY syndromes.Summary Answer: The SCA detection rate resulting from...

  • MONOCLONAL ANTIBODY AGAINST FREE BETA-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN. Conde, Ileana B. Baluja; Moreno, Adys I. Brito; Bas, Carmen Acosta; Rodríguez, Orlando Zulueta; Rodríguez, Antonio Melchor; Sanchéz, Isis Amores; Martínez, Luisa; Hernández, Milenen // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Spleen cells from BALB/c mice immunized with free native human chorionic gonadotropin hormone (-subunit ((hCG) were fused with mouse myeloma cells (P3/X63-Ag8) and one hybridoma secreting monoclonal antibodies, was obtained. This hybridoma specifically recognize (hCG and do not cross-react with...

  • Triploid pregnancy detected incidentally by Down's syndrome screening. Hanning, Ian; Mires, Gary J. // Annals of Clinical Biochemistry;Mar2002, Vol. 39 Issue 2, p157 

    Maternal serum screening for Down's syndrome and trisomy 18 identifies pregnancies with a greater risk of these abnormalities, which are then followed-up by karyotyping of cells collected either by amniocentesis or by chorionic villus sampling. These techniques complement ultrasonography, which...

  • Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Amor, D.J.; Xu, J.X.; Halliday, J.L.; Francis, I.; Healy, D.L.; Breheny, S.; Baker, H.W.G.; Jaques, A.M. // Human Reproduction;Jun2009, Vol. 24 Issue 6, p1330 

    : BACKGROUND First trimester screening (FTS) for Down syndrome combines measurement of nuchal translucency, free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein-A (PAPP-A). The aim of this study was to undertake a detailed analysis of FTS results in singleton...

  • Ethnic Differences in the Impact of Advanced Maternal Age on Birth Prevalence of Down Syndrome. Khoshnood, Babak; Pryde, Peter; Wall, Stephen; Singh, Jaideep; Mittendorf, Robert; Kwang-sun Lee // American Journal of Public Health;Nov2000, Vol. 90 Issue 11, p1778 

    Objectives. This study explored whether ethnic differences in the impact of advanced maternal age on the risk of Down syndrome might reflect differences in use of prenatal diagnostic technologies. Methods. Maternal age-specific odds of Down syndrome and amniocentesis use were compared among...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics